Nearly a quarter of a million Britons take the anti-smoking drug Champix. Should they continue when the FDA has now announced that it looks ‘increasingly likely’ that there is a connection between this drug and serious psychiatric problems? It emerged in December that seven deaths in Britain were thought to be linked to the pill.
